Sato S
Zen-Noh Institute of Animal Health, Chiba, Japan.
Rev Sci Tech. 1996 Dec;15(4):1555-67. doi: 10.20506/rst.15.4.984.
Since 1954, avian mycoplasmosis has been considered a significant problem in chicken flocks in Japan and in other Asian countries. In Japan, Mycoplasma gallisepticum (MG) and M. synoviae (MS) infections were confirmed aetiologically in chicken flocks affected with respiratory disease or synovitis in 1962 and 1973, respectively. In other Asian countries, including Indonesia, the People's Republic of China, Korea, Malaysia, the Philippines, Taipei China and Thailand, the occurrence of mycoplasmosis in chicken flocks has been recognised serologically or aetiologically. Adverse atmospheric and environmental conditions, in addition to mixed infections of bacterial or viral origin, play an important role in the spread of MG and MS within chicken flocks or in the induction of clinical respiratory mycoplasmosis. Serological tests are important in determining and monitoring the mycoplasmal infection status of chicken flocks. The establishment of mycoplasma-free breeding stocks is recognised as essential for the control of avian mycoplasmosis. To eliminate the transmission of MG to the egg, treatment of infected breeder flocks or their progeny with anti-mycoplasmal antibiotics was effective in considerably reducing the infection rate but not in entirely eliminating MG infection. The preincubation heat treatment of chicken hatching eggs has proved an effective procedure for establishing MG- and MS-free breeding stocks in Japan. Vaccination against MG infection has been practised successfully in Japan and other countries.
自1954年以来,禽支原体病一直被认为是日本及其他亚洲国家鸡群中的一个重大问题。在日本,1962年和1973年分别从患有呼吸道疾病或滑膜炎的鸡群中病因学确诊了鸡毒支原体(MG)和滑膜支原体(MS)感染。在其他亚洲国家,包括印度尼西亚、中华人民共和国、韩国、马来西亚、菲律宾、中国台北和泰国,鸡群中支原体病的发生已通过血清学或病因学得到确认。除了细菌或病毒源性的混合感染外,不利的大气和环境条件在MG和MS在鸡群中的传播或临床呼吸道支原体病的诱发中起重要作用。血清学检测对于确定和监测鸡群的支原体感染状况很重要。建立无支原体种鸡群被认为是控制禽支原体病的关键。为了消除MG向蛋中的传播,用抗支原体抗生素治疗感染的种鸡群或其后代可有效大幅降低感染率,但不能完全消除MG感染。在日本,鸡孵化蛋的孵化前热处理已被证明是建立无MG和无MS种鸡群的有效方法。在日本和其他国家,针对MG感染的疫苗接种已成功实施。